NCT04300114 2024-03-28
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Terminated
Clinical Trials
22 trialsNCT04592861 2024-01-05
Carbon Ion RT for Locally Advanced Pancreatic Cancer
Albert Einstein College of Medicine
Phase 3 Terminated
NCT04329949 2023-11-18
RELIANT
Corcept Therapeutics
Phase 3 Terminated
NCT03472833 2022-02-15
VITdCUT
Medical University of Graz
Phase 3 Terminated
NCT01956812 2021-08-16
PANCRIT®-1
Gilead Sciences
Phase 3 Terminated
NCT01836432 2020-05-28
PILLAR
Lumos Pharma
Phase 3 Terminated
NCT01314027 2019-07-25
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
University of Zurich
Phase 3 Terminated
NCT02404363 2019-07-25
PANCREADOGREL
Assistance Publique - HĂ´pitaux de Paris
Phase 3 Terminated
NCT02117479 2019-03-26
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)
Incyte Corporation
Phase 3 Terminated
NCT01900327 2018-05-11
NEOPA
Universitätsklinikum Hamburg-Eppendorf
Phase 3 Terminated
NCT02119663 2018-02-13
A Study of Ruxolitinib in Pancreatic Cancer Patients
Incyte Corporation
Phase 3 Terminated
NCT00637728 2016-06-23
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00574275 2016-06-07
VANILLA
Sanofi
Phase 3 Terminated
NCT00602745 2016-05-26
S-1 Pancreas
Sanofi
Phase 3 Terminated
NCT00031837 2015-10-14
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
Phase 3 Terminated
NCT01419002 2015-07-29
Net-Pac
CHIR-Net
Phase 3 Terminated
NCT01362582 2014-09-25
PANUSCO
National Center for Tumor Diseases, Heidelberg
Phase 3 Terminated
NCT00662688 2013-03-13
PAM07
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 3 Terminated
NCT00387348 2012-12-03
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Massachusetts General Hospital
Phase 3 Terminated
NCT00428597 2010-10-11
A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors
Pfizer
Phase 3 Terminated
NCT00014651 2010-08-10
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
Mayo Clinic
Phase 3 Terminated
NCT00358566 2008-05-19
GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
Pharmexa A/S
Phase 3 Terminated